Inovio Pharmaceuticals (INO) Short term Debt (2023)

Inovio Pharmaceuticals has disclosed Short term Debt across 1 years of filings, most recently posting $16.8 million for Q4 2023.

• In Q4 2023, Short term Debt changed N/A year-over-year to $16.8 million; the TTM figure through Dec 2023 stood at $16.8 million (changed N/A YoY), while the FY2023 annual figure was $16.8 million, changed N/A from the prior year.
• Short term Debt came in at $16.8 million for Q4 2023 at Inovio Pharmaceuticals, up from $16.5 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $16.8 million in Q4 2023 to a low of $16.4 million in Q1 2023.